CYNOSURE (CYNO) Alert: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Cynosure, Inc.

SAN DIEGO, Feb. 14, 2017 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Cynosure, Inc. (NASDAQ: CYNO) breached their fiduciary duties in connection with the proposed sale of the Company to Hologic, Inc.

On February 14, 2017, Cynosure announced it had signed a definitive merger agreement with Hologic. Under terms of the agreement, Hologic will acquire all of the outstanding shares of Cynosure for $66 per share.

The investigation concerns whether the Cynosure board failed to satisfy their duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Cynosure shares of common stock.

If you are a shareholder of Cynosure and believe the proposed buyout price is too low and you're interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker ([email protected]) at 619-814-4471.

About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
[email protected]

SOURCE Johnson & Weaver, LLP

Related Links

http://johnsonandweaver.com